INTEGRATED BIOPHARMA INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Integrated Biopharma Inc annual/quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q1 2024.
  • Integrated Biopharma Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 30.8M shares, a 2.22% decline year-over-year.
  • Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 30.9M shares, a 3.09% increase from 2023.
  • Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 29.9M shares, a 7.34% decline from 2022.
  • Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.3M shares, a 0.65% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 30.8M -699K -2.22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q2 2023 29.9M -2.37M -7.34% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-20
Q1 2023 31.5M -897K -2.77% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 29.9M -2.5M -7.7% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-10
Q3 2022 29.9M -2.65M -8.13% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 32.3M +208K +0.65% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 32.4M -503K -1.53% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 32.4M +348K +1.08% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 32.6M +807K +2.54% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 32.1M +956K +3.07% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 32.9M +1.98M +6.41% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 32.1M +1.51M +4.93% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 31.8M +1.07M +3.48% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 31.2M +1.57M +5.31% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 30.9M +777K +2.58% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 30.6M +693K +2.32% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 30.7M +2.76M +9.87% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 29.6M -731K -2.41% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 30.1M -93.6K -0.31% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 29.9M +8.76M +41.5% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 28M +6.83M +32.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 30.3M Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 30.2M -589K -1.91% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 21.1M +29.1K +0.14% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 21.1M -47.7K -0.23% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q1 2017 30.8M +9.51M +44.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 21.1M +924 +0% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 21.2M +27.7K +0.13% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q1 2016 21.3M +177K +0.84% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 21.1M -8.23M -28.1% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 21.2M -8.38M -28.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 29.4M +8.19M +38.7% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 21.1M +25K +0.12% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 29.3M -48K -0.16% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 29.5M +135K +0.46% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 21.2M -49.8K -0.23% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 21.1M 0 0% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 29.4M -147K -0.5% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 29.4M +8.32M +39.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 21.2M +232K +1.11% Apr 1, 2013 Jun 30, 2013 10-K 2014-09-08
Q1 2013 21.1M +43.7K +0.21% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 29.5M +8.54M +40.7% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-13
Q3 2012 21.1M +143K +0.69% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-19
Q2 2012 21M Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 21M +250K +1.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 21M +190K +0.91% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 20.9M +311K +1.51% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q1 2011 20.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 20.8M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
Q3 2010 20.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.